The influence of age on induced sputum differential cell counts in normal subjects.

The influence of age on induced sputum differential cell counts in normal subjects.

STUDY OBJECTIVES: Sputum induction is increasingly used as a research technique and as a clinical tool. In order to evaluate abnormal results, normal ranges need to be fully developed. Although a number of studies have described normal ranges, none have investigated the effect of the age of the sub...

Bibliografske podrobnosti
Main Authors:	Thomas, R, Green, R, Brightling, C, Birring, S, Parker, D, Wardlaw, A, Pavord, I
Format:	Journal article
Jezik:	English
Izdano:	2004

Podobne knjige/članki

Induced sputum inflammatory mediator concentrations in chronic cough.
od: Birring, S, et al.
Izdano: (2004)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
od: Green, R, et al.
Izdano: (2002)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
od: Green, R, et al.
Izdano: (2002)

Between observer repeatability of sputum differential cell counts. Influence of cell viability and squamous cell contamination
od: Ward, R, et al.
Izdano: (1997)

Between-observer repeatability of sputum differential cell counts. Influence of cell viability and squamous cell contamination.
od: Ward, R, et al.
Izdano: (1999)

Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability.
od: Brightling, C, et al.
Izdano: (2001)

Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study.
od: Birring, S, et al.
Izdano: (2002)

Sputum eosinophilia in idiopathic pulmonary fibrosis.
od: Birring, S, et al.
Izdano: (2005)

Sputum neutrophil counts in healthy subjects: relationship with age
od: Augusta Beech, et al.
Izdano: (2022-11-01)

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
od: Brightling, C, et al.
Izdano: (2005)

Induced sputum eicosanoid concentrations in asthma.
od: Pavord, I, et al.
Izdano: (1999)

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
od: Brightling, C, et al.
Izdano: (2000)

Multiple inflammatory hits and the pathogenesis of severe airway disease.
od: Pavord, I, et al.
Izdano: (2006)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
od: Saha, S, et al.
Izdano: (2008)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
od: Brightling, C, et al.
Izdano: (2000)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
od: Brightling, C, et al.
Izdano: (2000)

Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.
od: Saha, S, et al.
Izdano: (2008)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
od: Berry, M, et al.
Izdano: (2004)

Establishing a Normal Range for Induced Sputum Cell Counts in Western Canada
od: Warren J Davidson, et al.
Izdano: (2013-01-01)

A case of cough, lymphocytic bronchoalveolitis and coeliac disease with improvement following a gluten free diet.
od: Brightling, C, et al.
Izdano: (2002)

Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis.
od: Birring, S, et al.
Izdano: (2003)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
od: Woltmann, G, et al.
Izdano: (1999)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
od: Brightling, C, et al.
Izdano: (2002)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
od: Brightling, C, et al.
Izdano: (2003)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
od: Bafadhel, M, et al.
Izdano: (2009)

Management of asthma in adults: current therapy and future directions.
od: Green, R, et al.
Izdano: (2003)

The safety and success rate of sputum induction using a low output ultrasonic nebuliser.
od: Hunter, C, et al.
Izdano: (1999)

Bacteria and sputum inflammatory cell counts; a COPD cohort analysis
od: Augusta S. Beech, et al.
Izdano: (2020-11-01)

Neutrophil count in sputum is associated with increased sputum glucose and sputum L-lactate in cystic fibrosis.
od: Bibi Uhre Nielsen, et al.
Izdano: (2020-01-01)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
od: Ian D. Pavord, et al.
Izdano: (2022-05-01)

Measurement of Markers of Inflammation in Induced Sputum and Exhaled Air
od: Pavord, I, et al.
Izdano: (2009)

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
od: Agbetile, J, et al.
Izdano: (2012)

Asthma exacerbations and sputum eosinophil counts.
od: Currie, G, et al.
Izdano: (2003)

The use of induced sputum to investigate airway inflammation
od: Pavord, I, et al.
Izdano: (1997)

The use of induced sputum to investigate airway inflammation.
od: Pavord, I, et al.
Izdano: (1997)

Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma.
od: Desai, D, et al.
Izdano: (2013)

The use of induced sputum in clinical trials.
od: Kips, J, et al.
Izdano: (2002)

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap
od: Gao J, et al.
Izdano: (2017-09-01)

Eosinophilic bronchitis: clinical features, management and pathogenesis.
od: Birring, S, et al.
Izdano: (2003)

Cough and asthma.
od: Berry, M, et al.
Izdano: (2003)